The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Feb. 08, 2018
Applicant:

Shenzhen Catalys Technology Co., Ltd, Shenzhen, CN;

Inventors:

Xumu Zhang, Shenzhen, CN;

Genqiang Chen, Shenzhen, CN;

Jiaming Huang, Shenzhen, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 15/00 (2006.01); B01J 31/22 (2006.01); B01J 31/24 (2006.01); C07C 51/36 (2006.01); C07F 9/6561 (2006.01);
U.S. Cl.
CPC ...
C07F 15/0046 (2013.01); B01J 31/2213 (2013.01); B01J 31/249 (2013.01); C07C 51/36 (2013.01); C07F 9/6561 (2013.01); B01J 2231/645 (2013.01); B01J 2531/821 (2013.01); C07B 2200/07 (2013.01);
Abstract

The present invention relates to the technical field of chiral synthesis, and specifically provides a new type of oxa-spirodiphosphine ligands. The bisphosphine ligand is prepared with oxa-spirobisphenol as a starting material after triflation, palladium catalyzed coupling with diaryl phosphine oxide, reduction of trichlorosilane, further palladium catalyzed coupling with diaryl phosphine oxide, and further reduction of trichlorosilane. The oxa-spiro compound has central chirality, and thus includes L-oxa-spirodiphosphine ligand and R-oxa-spirodiphosphine ligand. The racemic spirodiphosphine ligand is capable of being synthesized from racemic oxa-spirobisphenol as a raw material. The present invention can be used as a chiral ligand in the asymmetric hydrogenation of unsaturated carboxylic acids. The complex of the ligand with ruthenium can achieve an enantioselectivity of greater than 99% in the asymmetric hydrogenation of methyl-cinnamic acid.


Find Patent Forward Citations

Loading…